Central and autonomic system signs with in utero drug exposure

Bada, H.S.; Bauer, C.R.; Shankaran, S.; Lester, B.; Wright, L.L.; Das, A.; Poole, K.; Smeriglio, V.L.; Finnegan, L.P.; Maza, P.L.
September 2002
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2002, Vol. 87 Issue 2, pF106
Academic Journal
Aims: To determine risk for central nervous system/autonomic nervous system (CNS/ANS) signs following in utero cocaine and opiate exposure. Methods: A multisite study was designed to determine outcomes of in utero cocaine and opiate exposure. A total of 11 811 maternal/infant dyads were enrolled. Drug exposed (EXP) infants were identified by maternal self report of cocaine or opiate use or by meconium testing. Of 1185 EXP, meconium analysis confirmed exposure in 717 to cocaine (CO) only, 100 to opiates (OP), and 92 to opiates plus cocaine (OP+CO); 276 had insufficient or no meconium to confirm maternal self report. Negative exposure history was confirmed in 7442 by meconium analysis and unconfirmed in 3184. Examiners masked to exposure status, assessed each enrolled infant. Using generalised estimating equations, adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated for manifesting a constellation of CNS/ANS outcomes and for each sign associated with cocaine and opiate exposure. Results: Prevalence of CNS/ANS signs was low in CO, and highest in OP+CO. Signs were significantly related to one another. After controlling for confounders, CO was associated with increased risk of manifesting a constellation of CNS/ANS outcomes, OR (95% CI): 1.7 (1.2 to 2.2), independent of OP effect, OR (95% CI): 2.8 (2.1 to 3.7). OP+CO had additive effects, OR (95% CI): 4.8 (2.9 to 7.9). Smoking also increased the risk for the constellation of CNS/ANS signs, OR (95% CI) of 1.3 (1.04 to 1.55) and 1.4 (1.2 to 1.6), respectively, for use of less than half a pack per day and half a pack per day or more. Conclusion: Cocaine or opiate exposure increases the risk for manifesting a constellation of CNS/ANS outcomes.


Related Articles

  • Editorial: New Therapeutic Options in Central Nervous System Involvement of Rheumatologic Diseases. Gur, Ali // Current Pharmaceutical Design;May2008, Vol. 14 Issue 13, p1240 

    The article discusses various reports published within the issue including one about the mechanisms of immune-to-brain signaling that may contribute to disease-related changes in mood, affect and behavior in chronic inflammatory rheumatic diseases and another on central nervous system...

  • Post-artdenoviral parasympathetic dysautonomia in a child: a case report. McLoughlin, Terence F.; Martinez, Adalaida // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: This is the first reported case of adenoviral meningoencephalitis that was complicated by persistent parasympathetic dysautonomia, which clinically either stimulated or inhibited its activity. Case presentation: A 7-year-old Caucasian girl presented to our hospital in March 2008...

  • psychoneuroimmunology.  // Taber's Cyclopedic Medical Dictionary;2005, p1809 

    A definition of the term "psychoneuroimmunology" is presented. It refers to the study of the relationships among the central nervous system, autonomic nervous system, endocrine system and immune system. The data are gathered from studies to examine the impact of psychosocial stressors and the...

  • Conditions of activity bubble uniqueness in dynamic neural fields. Mikhailova, Inna; Goerick, Christian // Biological Cybernetics;Feb2005, Vol. 92 Issue 2, p82 

    Dynamic neural fields (DNFs) offer a rich spectrum of dynamic properties like hysteresis, spatiotemporal information integration, and coexistence of multiple attractors. These properties make DNFs more and more popular in implementations of sensorimotor loops for autonomous systems. Applications...

  • Autonomic function and spinal cord injury: are we at a crossroads? Alexander, M. S. // Spinal Cord;Jun2008, Vol. 46 Issue 6, p402 

    Study design:This presentation was originally given as ‘The Sullivan Lecture’ at the International Spinal Cord Society Meeting in Reykjavik, Iceland on 30 June 2007.Setting:Named lecture at an international meeting.Results:The development of the autonomic component standards of the...

  • Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment. Gur, Ali; Oktayoglu, Pelin // Current Pharmaceutical Design;May2008, Vol. 14 Issue 13, p1274 

    Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are poorly understood disorders that share similar demographic and clinical characteristics. The etiology and pathophysiology of these diseases remain unclear. Because of the similarities between both disorders it was suggested that they share...

  • Altered baroreflex gain during voluntary breathing in chronic heart failure. Mangin, L.; Monti, A.; Médigue, C.; Macquin-Mavier, I.; Lopes, M.-E.; Gueret, P.; Castaigne, A.; Swynghedauw, B.; Mansier, P. // European Journal of Heart Failure;Mar2001, Vol. 3 Issue 2, p189 

    Background:: We assessed the behavior of the baroreflex (BR) gain in chronic heart failure (CHF) patients using the spectral analysis method during application of a forcing stimulus, i.e. respiration.

  • Central Nervous System Plasticity and Persistent Pain. Ren, Ke; Dubner, Ronald // Journal of Orofacial Pain;Summer1999, Vol. 13 Issue 3, p155 

    Nerve signals arising from sites of tissue or nerve injury lead to long-term changes in the central nervous system and contribute to hyperalgesia and the amplification and persistence of pain. These nociceptor activity-induced changes are referred to as central sensitization. Central...

  • Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment. Johnson, Bankole A. // CNS Drugs;2004, Vol. 18 Issue 15, p1105 

    Preclinical studies have contributed greatly to our understanding of the neurochemical pathways associated with the development and maintenance of alcohol-seeking behaviour. These studies have demonstrated the important role of serotonin pathways, particularly as they relate to dopaminergic...


Read the Article


Sign out of this library

Other Topics